Vascular Biogen. Ord (VBLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VBLT | AMGN | VRTX | REGN | BMY |
| Company | Vascular Biogen. Ord | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 6.0690 | 269.18 | 397.48 | 883.20 | 45.09 |
| High | 6.7375 | 276.36 | 399.31 | 897.78 | 45.38 |
| Low | 5.3410 | 268.99 | 395.67 | 883.20 | 44.61 |
| Last | 5.4600 | 275.68 | 396.28 | 892.95 | 44.66 |
| Change | -0.5250 | +5.70 | -1.20 | +9.75 | -0.19 |
| % Change | -8.77% | +2.11% | -0.30% | +1.10% | -0.42% |
| Volume | 161,505 | 1,050,603 | 299,686 | 174,707 | 8,674,374 |
| 20-Day Average Volume | 1,006,195 | 2,111,022 | 919,484 | 447,295 | 13,139,104 |
| Previous Close | 5.9850 | 269.98 | 397.48 | 883.20 | 44.85 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.2249 | 269.61 | 400.08 | 914.84 | 49.06 |
| 20-Day Raw Stochastic | 2.51% | 63.88% | 18.50% | 23.10% | 3.94% |
| 20-Day Relative Strength | 35.56% | 51.19% | 41.85% | 38.69% | 28.78% |
| Weighted Alpha | +1.00 | +13.51 | +12.57 | +15.70 | -35.25 |
| Today's Opinion | 40% Sell | 24% Sell | 8% Sell | 8% Buy | 88% Sell |
| Previous Opinion | 40% Sell | 72% Sell | 8% Buy | 8% Sell | 88% Sell |
| Last Month's Opinion | 24% Buy | 24% Buy | 56% Buy | 80% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -33.76% since 10/09/23 | +1.33% since 04/22/24 | -0.85% since 04/22/24 | -0.54% since 04/22/24 | -9.05% since 04/22/24 |
| Low | 0.1526 on 10/16/23 | 265.72 on 04/26/24 | 393.00 on 04/25/24 | 875.22 on 04/26/24 | 44.34 on 04/26/24 |
| High | 0.2880 on 10/12/23 | 275.77 on 04/29/24 | 406.86 on 04/23/24 | 915.70 on 04/24/24 | 49.47 on 04/23/24 |
| 1-Month | |||||
| %Chg | -33.33% since 09/15/23 | -3.10% since 03/28/24 | -5.14% since 03/28/24 | -6.98% since 03/28/24 | -17.58% since 03/28/24 |
| Low | 0.1526 on 10/16/23 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 44.34 on 04/26/24 |
| High | 0.2880 on 10/12/23 | 283.91 on 04/02/24 | 421.45 on 04/01/24 | 970.20 on 04/01/24 | 54.23 on 04/01/24 |
| 3-Month | |||||
| %Chg | -46.99% since 07/14/23 | -12.10% since 01/29/24 | -9.01% since 01/29/24 | -6.33% since 01/29/24 | -10.38% since 01/29/24 |
| Low | 0.1526 on 10/16/23 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 44.34 on 04/26/24 |
| High | 0.3098 on 07/25/23 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | -20.93% since 04/14/23 | +5.33% since 10/27/23 | +11.61% since 10/27/23 | +15.50% since 10/27/23 | -12.40% since 10/27/23 |
| Low | 0.1520 on 04/25/23 | 249.70 on 10/31/23 | 341.90 on 11/16/23 | 772.84 on 10/31/23 | 44.34 on 04/26/24 |
| High | 0.3200 on 07/13/23 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 12,112 | 144,810,784 | 102,732,288 | 96,941,800 | 90,900,144 |
| Shares Outstanding, K | 77,640 | 536,376 | 258,459 | 109,762 | 2,026,759 |
| Annual Sales | 660,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -32,300,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 | 11,477,000,000 |
| Last Quarter Net Income | -870,000 | 767,000,000 | 968,800,000 | 1,159,600,000 | 1,762,000,000 |
| 60-Month Beta | 0.76 | 0.58 | 0.35 | 0.11 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.01 on 08/14/23 | 4.71 on 02/06/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 11/13/23 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.44 | 29.59 | 23.70 | 6.08 |